SLC5A2 and hydrops fetalis: Thus, our study did not evaluate the impact of ARNI, which is a pivotal HF medication in recent years, nor were they treated by SGLT2-inihibitors, which were recently shown to be HF modifying drugs as well; (f) only VA necessitating ICD/CRTD interventions were evaluated.